Metrics as of 10/17/2026, 08:24 AM (Berlin time), refresh in progress.
Idorsia Stock
Idorsia Ltd
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Switzerland
- CEO
- Roland Wandeler
- Employees
- 456
- Market cap
- CHF1.1 B
- IPO
- 16/06/2017
Idorsia Ltd is a biopharmaceutical company operating in the healthcare sector that focuses on the discovery, development, and commercialization of drugs for unmet medical needs. Headquartered in Allschwil, Switzerland, the company was incorporated in 2017. Its therapeutic pipeline covers various areas including CNS,…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Idorsia stock: price history
1D
-2.4%
1W
-2.4%
1M
-17.2%
6M
+10.5%
YTD
-3.8%
1Y
+3.8%
2Y
+238.8%
5Y
-80.1%
10Y
–
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~22% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 12/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Idorsia
Idorsia stock metrics
P/E
-3.13
P/B
-0.88
EV/EBITDA
-12.81
RETURN ON EQUITY
9.0%
NET MARGIN
-201.9%
DEBT/EQUITY
-1.1
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
75.9%
FLOAT SHARES
204,287,128
AVG. DAILY VOLUME (30D)
1,114,471
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Idorsia stock
What does Idorsia do?
Idorsia Ltd is a company in the Healthcare sector, Biotechnology industry, headquartered in Switzerland.
The CEO is Roland Wandeler, the company employs around 456 people.
The IPO was on 16/06/2017; the stock trades on SIX under the ticker IDIA.SW.
When does Idorsia report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 22% stronger than usual.
Does Idorsia pay a dividend?
Yes. The last dividend was CHF 12.00 per share.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Idorsia?
Comparable stocks include BeOne Medicines, Pharvaris, Basilea Pharmaceutica, Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx and Revolution Medicines.
How can I get Idorsia stock analyzed?
Clicking "Analyze stock" lets five strategies assess Idorsia against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.